Company · CIK 0001566044 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Yarrow Bioscience, Inc. · YARW
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 JForm 4 → | Jul 30, 4:05 pm EDT | RTW Fund Group GP, LLC +110% Owner | 133,290 | — | — | 266,307 | — | |
| Jul 23, 2026 FForm 4 → | Jul 24, 5:00 pm EDT | Tyler ZerondaCHIEF FINANCIAL OFFICER | 22,516 | $0.8976 | $20,210 | 74,918 | — | |
| Jul 23, 2026 FForm 4 → | Jul 24, 5:00 pm EDT | Iain StuartCHIEF SCIENTIFIC OFFICER | 15,405 | $0.8976 | $13,828 | 95,944 | — | |
| Jul 23, 2026 FForm 4 → | Jul 24, 5:00 pm EDT | Mutya HarschCHIEF LEGAL OFFICER AND GC | 22,516 | $0.8976 | $20,210 | 95,918 | — | |
| Jul 23, 2026 FForm 4 → | Jul 24, 5:00 pm EDT | David DomzalskiPRESIDENT AND CEO, Director | 79,391 | $0.8976 | $71,261 | 347,174 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 8:05 pm EDT | Tyler ZerondaCHIEF FINANCIAL OFFICER | 3,464 | $0.6507 | $2,254 | 97,434 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 8:05 pm EDT | Iain StuartCHIEF SCIENTIFIC OFFICER | 2,370 | $0.6507 | $1,542 | 111,349 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 8:05 pm EDT | Mutya HarschCHIEF LEGAL OFFICER AND GC | 3,464 | $0.6507 | $2,254 | 118,434 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 8:05 pm EDT | David DomzalskiPRESIDENT AND CEO, Director | 12,214 | $0.6507 | $7,948 | 426,565 | — | |
| Jul 24, 2018 SForm 4 → | Jul 26, 7:11 pm EDT | Presidio Partners 2007 GP, L.P. +5Other | 500,000 | $7.65 | $3,825,000 | 48,910 | −91.1% | plan? |
| Mar 2, 2018 JForm 4 → | Jul 26, 6:54 pm EDT | Presidio Partners 2007 GP, L.P. +510% Owner | 152,062 | — | — | 152,062 | — | plan? late |
| Jan 29, 2018 CForm 4 → | Jan 31, 4:31 pm EST | FMR LLCOther | 1,118,054 | — | — | 1,118,054 | — | plan? amended |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:25 pm EST | Presidio Partners 2007 GP, L.P. +510% Owner | 1,004,765 | — | — | 61,410 | — | plan? |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:22 pm EST | venBio Global Strategic Fund II L.P.10% Owner | 1,196,552 | — | — | 1,461,552 | — | plan? |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:19 pm EST | Remeditex Ventures LLC10% Owner | 1,178,809 | — | — | 2,761,663 | — | plan? |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:17 pm EST | Vivo Capital VIII, LLC +210% Owner | 3,717,118 | — | — | 486,695 | — | plan? |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:14 pm EST | Albert ChaDirector | 3,717,118 | — | — | 486,695 | — | plan? |
| Jan 25, 2018 PForm 4 → | Jan 29, 4:22 pm EST | venBio Global Strategic Fund II L.P.10% Owner | 265,000 | $17.00 | $4,505,000 | 265,000 | — | plan? |
| Jan 25, 2018 PForm 4 → | Jan 29, 4:19 pm EST | Remeditex Ventures LLC10% Owner | 100,000 | $17.00 | $1,700,000 | 1,582,854 | +6.74% | plan? |
| Jan 25, 2018 PForm 4 → | Jan 29, 4:17 pm EST | Vivo Capital VIII, LLC +210% Owner | 294,118 | $17.00 | $5,000,006 | 35,686 | — | plan? |
| Jan 25, 2018 PForm 4 → | Jan 29, 4:14 pm EST | Albert ChaDirector | 294,118 | $17.00 | $5,000,006 | 35,686 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 JForm 4 → | Jul 30, 4:05 pm EDT | RTW Fund Group GP, LLC +110% Owner | 133,290 | — | — | 8,949,719 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 9:36 pm EDT | Mona AshiyaDirector | 15,435 | — | — | 15,435 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 9:33 pm EDT | Tyler ZerondaDirector | 185,798 | — | — | 185,798 | — | |
| Jan 14, 2019 MForm 4 → | Jan 15, 4:22 pm EST | Scott M WhitcupDirector | 25,000 | $1.83 | $45,858 | 77,043 | — | |
| Dec 10, 2018 AForm 4 → | Dec 12, 6:43 pm EST | Mary SpellmanChief Medical Officer | 96,000 | — | — | 96,000 | — | |
| Dec 10, 2018 AForm 4 → | Dec 12, 6:43 pm EST | Paul KwonChief Scientific Officer | 64,000 | — | — | 64,000 | — | |
| Dec 10, 2018 AForm 4 → | Dec 12, 6:42 pm EST | Steven L BastaChief Executive Officer, Director | 141,900 | — | — | 141,900 | — | |
| Dec 10, 2018 AForm 4 → | Dec 12, 6:41 pm EST | Kristine M BallSVP, Corporate Strategy & CFO | 96,000 | — | — | 96,000 | — | |
| May 3, 2018 AForm 4 → | May 4, 4:36 pm EDT | Paul KwonChief Medical Officer | 64,000 | — | — | 252,512 | — | |
| May 3, 2018 AForm 4 → | May 4, 4:34 pm EDT | Kristine M BallSee Remarks | 64,000 | — | — | 237,123 | — | |
| May 3, 2018 AForm 4 → | May 4, 4:31 pm EDT | Steven L BastaChief Executive Officer, Director | 212,850 | — | — | 669,400 | — | |
| Jan 29, 2018 CForm 4 → | Jan 31, 4:31 pm EST | FMR LLCOther | 3,015,953 | — | — | 0 | — | amended |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:25 pm EST | Presidio Partners 2007 GP, L.P. +510% Owner | 2,723,346 | — | — | 0 | — | |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:22 pm EST | venBio Global Strategic Fund II L.P.10% Owner | 3,227,700 | — | — | 0 | — | |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:19 pm EST | Remeditex Ventures LLC10% Owner | 3,179,843 | — | — | 0 | — | |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:17 pm EST | Vivo Capital VIII, LLC +210% Owner | 10,026,934 | — | — | 0 | — | |
| Jan 29, 2018 CForm 4 → | Jan 29, 4:14 pm EST | Albert ChaDirector | 10,026,934 | — | — | 0 | — |